Top news
Oxford vaccine trial on hold because of potential safety issue
By Erika Edwards, Sara G. Miller & Meg Tirrell
AstraZeneca CEO says participant had neurological symptoms, could be discharged today
By Adam Feuerstein
Safety Review Begins Into AstraZeneca's Coronavirus Vaccine Trial
By Katherine J. Wu
All coverage
AstraZeneca pauses COVID-19 vaccine trial over possible adverse reaction in participant
By Jordan Freiman
The ethics of pausing a vaccine trial in the midst of a pandemic: a conversation with Ruth Faden
By Patrick J. Skerrett
AstraZeneca Covid-19 vaccine study put on hold due to suspected adverse reaction in participant in the U.K.
By Rebecca Robbins, Helen Branswell & Adam Feuerstein
AstraZeneca Pauses Vaccine Trial for Safety Review
By Katie Thomas & Katherine J. Wu